MesylatesErgoloid MesylatesAminationPalladiumBenzamidesPiperazinesPyrimidinesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGastrointestinal Stromal TumorsAntineoplastic AgentsFusion Proteins, bcr-ablProtein Kinase InhibitorsDrug Resistance, NeoplasmEarly Detection of CancerLeukemia, Myeloid, Chronic-PhaseProto-Oncogene Proteins c-kitProstatic NeoplasmsReceptor, Platelet-Derived Growth Factor alphaOvarian NeoplasmsBreast NeoplasmsLung NeoplasmsStomach NeoplasmsGenes, ablGastrointestinal NeoplasmsNeoplasm MetastasisColonic NeoplasmsK562 CellsCell Line, TumorThiazolesMice, NudeGene Expression Regulation, NeoplasticProtein-Tyrosine KinasesAntineoplastic Combined Chemotherapy ProtocolsNeoplasm InvasivenessSurvival AnalysisNeoplasmsDisease-Free SurvivalProto-Oncogene Proteins c-ablTreatment OutcomeSurvival RateMutationNeoplasm ProteinsDisease ProgressionPrognosisBlast CrisisPancreatic NeoplasmsCancer VaccinesReverse Transcriptase Polymerase Chain ReactionCytogenetic AnalysisFollow-Up StudiesRetrospective StudiesRNA, MessengerDose-Response Relationship, DrugXenograft Model Antitumor AssaysUterine Cervical NeoplasmsNeoplasm Recurrence, LocalApoptosisTumor Markers, BiologicalGenetic Predisposition to DiseaseCell ProliferationGene Expression ProfilingProspective StudiesCarcinomaPhiladelphia ChromosomeCarcinoma, Non-Small-Cell LungCombined Modality TherapyBlotting, WesternRiskHypereosinophilic SyndromeNeoplastic Stem CellsUrinary Bladder NeoplasmsCarcinoma, Squamous CellNational Cancer Institute (U.S.)Drug Administration ScheduleCell SurvivalNeoplasm StagingLeukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeRisk AssessmentRemission InductionColorectal NeoplasmsChemotherapy, AdjuvantKaplan-Meier EstimateReceptors, EstrogenRegistriesNeoplasm TransplantationUnited StatesRNA, Small Interfering